![ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate structure, CAS 157115-85-0](/structures/100000/93413_1_157115_85_0.png)
CAS Number157115-85-0
SynonymsEthyl 1-(phenylacetyl)-L-prolylglycinate; Glycine, 1-(2-phenylacetyl)-L-prolyl-, ethyl ester; ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate; Noopept; N-phenylacetyl-L-prolylglycine ethyl ester; GVS-111; Nopept
Molecular FormulaC17H22N2O4
Molecular Weight318.37
Purity≥98 (HPLC)%
Density1.2±0.1 g/cm3
Boiling Point547.3±50.0 °C at 760 mmHg
Melting Point94.0 to 98.0 °C
Appearancepowder
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 157115-85-0 |
| Catalog No. | 2A-9093413 |
| Chinese Name | N-(1-(苯基乙酰基)-L-脯氨酰)甘氨酸乙酯 |
| Synonyms | Ethyl 1-(phenylacetyl)-L-prolylglycinate; Glycine, 1-(2-phenylacetyl)-L-prolyl-, ethyl ester; ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate; Noopept; N-phenylacetyl-L-prolylglycine ethyl ester; GVS-111; Nopept |
| Molecular Formula | C17H22N2O4 |
| Molecular Weight | 318.37 |
| Purity | ≥98 (HPLC) |
| Density | 1.2±0.1 g/cm3 |
| Boiling Point | 547.3±50.0 °C at 760 mmHg |
| Melting Point | 94.0 to 98.0 °C |
| Appearance | powder |
| Storage Condition | -20°C |
| Application | Noopept (GVS-111) is a peptide available as a dietary supplement. |
| HTC | 2942000000 |
| PubChem ID | 329825678 |
| MDL Number | MFCD00941121 |
| SMILES | O=C(CC1=CC=CC=C1)N2CCC[C@H]2C(NCC(OCC)=O)=O |
| InChI | 1S/C17H22N2O4/c1-2-23-16(21)12-18-17(22)14-9-6-10-19(14)15(20)11-13-7-4-3-5-8-13/h3-5,7-8,14H,2,6,9-12H2,1H3,(H,18,22)/t14-/m0/s1 |
| InChI Key | PJNSMUBMSNAEEN-AWEZNQCLSA-N |
| NACRES Code | NA.77 |
| UNSPSC | 12352200 |
| MSDS | msds/93413_1_157115_85_0.pdf |
| Use of | Properties Name (S)-Ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxamido)acetate Synonym More Synonyms Noopept Biological Activity Related Catalog Signaling Pathways >> Membrane Transporter/Ion Channel >> iGluR Signaling Pathways >> Neuronal Signaling >> iGluR Research Areas >> Neurological Disease References [1]. Firstova IuIu, et al. Studying specific effects of nootropic drugs on glutamate receptors in the rat brain. Eksp Klin Farmakol. 2011;74(1):6-10. [2]. Pelsman A, et al. GVS-111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons. Int J Dev Neurosci. 2003 May;21(3):117-24. [3]. Ostrovskaya RU, et al. Memory restoring and neuroprotective effects of the proline-containing dipeptide, GVS-111, in a photochemical stroke model. Behav Pharmacol. 1999 Sep;10(5):549-53. [4]. Gudasheva TA, et al. The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-L-prolylglycine. Eur J Drug Metab Pharmacokinet. 1997 Jul-Sep;22(3):245-52. [5]. Kovalenko LP, et al. Anti-inflammatory properties of noopept (dipeptide nootropic agent GVS-111). Eksp Klin Farmakol. 2002 Mar-Apr;65(2):53-5. [6]. Kovalenko LP, et al. Preclinical study of noopept toxicity. Eksp Klin Farmakol. 2002 Jan-Feb;65(1):62-4. Chemical & Physical Properties Molecular Formula C17H22N2O4 Exact Mass 318.157959 PSA 75.71000 Index of Refraction 1.549 InChIKey PJNSMUBMSNAEEN-AWEZNQCLSA-N Safety Information RIDADR NONH for all modes of transport RTECS MC0814400 HS Code 2942000000 Synthetic Route Total: 1 Page (S)-1-(2-phenyl... CAS#:2752-38-7 CAS#:157115-85-0 Literature: European Journal of Medicinal Chemistry, , vol. 31, # 2 p. 151 - 157 Phenylacetyl ch... CAS#:103-80-0 CAS#:157115-85-0 Literature: European Journal of Medicinal Chemistry, , vol. 31, # 2 p. 151 - 157 CAS#:147-85-3 CAS#:157115-85-0 Literature: European Journal of Medicinal Chemistry, , vol. 31, # 2 p. 151 - 157 Precursor & DownStream Precursor 3 CAS#:2752-38-7 (S)-1-(2-phenyl... CAS#:103-80-0 Phenylacetyl ch... CAS#:147-85-3 DownStream 1 CAS#:157115-95-2 2-[[(2S)-1-(2-p... |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Product name: Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| Related Products in Heterocyclic Building Blocks | ||
|---|---|---|
| (2S)-2-Morpholinemethanol hydrochloride | 1313584-92-7 | 2A-9093377 |
| 2-chloro-5-fluoro-4-methoxypyrimidine | 37554-70-4 | 2A-9093399 |
| 2-Methoxy-5-fluoro-4-aminopyrimidine | 1993-63-1 | 2A-9093400 |
| 4-chloro-5-fluoro-2-methoxypyrimidine | 1801-06-5 | 2A-9093402 |
| Pyridine, 4-chloro-2,3-dimethyl- (9CI) | 315496-27-6 | 2A-9093409 |
| Piperazine, 1-benzoyl-4-(1-oxopropyl)- | 314728-85-3 | 2A-9093416 |
| N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide | 1346572-63-1 | 2A-9093452 |
| 7H-Pyrrolo[3,4-b]pyridin-7-one, 5,6-dihydro-3-Methoxy- | 1256791-04-4 | 2A-9093455 |
| 2-Pyridineacetic acid, a,a-difluoro- | 1039621-73-2 | 2A-9093460 |
| tert-butyl 3-(1H-pyrazol-3-yl)pyrrolidine-1-carboxylate | 1225218-81-4 | 2A-9093461 |
| Browse all Heterocyclic Building Blocks products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA